Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests
About this episode
The episode discusses advances in colorectal cancer detection, focusing on blood-based tests and their implications for screening.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients. Joining Dr. Peter Buch to talk about current recommendations and potential future directions for colorectal cancer screening is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor of Population Health at NYU Grossman School of Medicine, as well as the Director of Outcomes Research in the Division of Gastroenterology and Hepatology at NYU Langone Health. She's also a co-author of a recent review on blood tests for colorectal cancer.
More episodes of GI Insights
- Assessing Racial Disparities in Colorectal Cancer Screening
- Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
- Strategies for Increasing Colorectal Cancer Screening Rates
- Adenoma Detection Rate: A Prediction of Colorectal Cancer
- Colorectal Cancer in Young Patients: A Multidisciplinary Approach
- Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
Explore listener stats, chart rankings, contacts and more on the GI Insights podcast page.